Cargando…

Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Boykin, C, Zhang, G, Chen, Y-H, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304433/ http://dx.doi.org/10.1038/bjc.2012.77

Ejemplares similares

Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
por: Boykin, C, et al.
Publicado: (2011)

Corrigendum to “Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells”
por: Jung, Ji Hoon, et al.
Publicado: (2018)

Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells
por: Brouwer, Isabella J., et al.
Publicado: (2020)

Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2/STAT3 signalling pathway in vivo and in vitro
por: Xu, Dongchao, et al.
Publicado: (2022)

Corrigendum: Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae
por: Basgall, Erianna M., et al.
Publicado: (2018)

Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway
por: Murtaza, Munazza, et al.
Publicado: (2017)

Synthesis of cucurbitacin IIa derivatives with apoptosis-inducing capabilities in human cancer cells
por: Yu, Kun, et al.
Publicado: (2020)

Class IIa HDAC Downregulation Contributes to Surgery-Induced Cognitive Impairment Through HMGB1-Mediated Inflammatory Response in the Hippocampi of Aged Mice [Corrigendum]
Publicado: (2021)

Corrigendum to “JAK2/STAT3 Pathway Was Associated with the Protective Effects of IL-22 on Aortic Dissection with Acute Lung Injury”
por: Ren, Wei, et al.
Publicado: (2019)

Corrigendum to “Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest”
por: Duangmano, Suwit, et al.
Publicado: (2015)

Corrigendum to “Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia”
por: Zhong, Liren, et al.
Publicado: (2020)

Cucurbitacin I Inhibits Cell Motility by Indirectly Interfering with Actin Dynamics
por: Knecht, David A., et al.
Publicado: (2010)

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients
por: Tonini, G, et al.
Publicado: (2005)

VASP Activation via the Gα13/RhoA/PKA Pathway Mediates Cucurbitacin-B-Induced Actin Aggregation and Cofilin-Actin Rod Formation
por: Zhang, Yan-Ting, et al.
Publicado: (2014)

Corrigendum to “Salvianolic Acid B Protects Intervertebral Discs from Oxidative Stress-Induced Degeneration via Activation of the JAK2/STAT3 Signaling Pathway”
por: Dai, Shouqian, et al.
Publicado: (2022)

Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
Publicado: (2020)

Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 Pathways
por: Liu, Yang, et al.
Publicado: (2020)

Repeated Intravenous Administration of Silica Nanoparticles Induces Pulmonary Inflammation and Collagen Accumulation via JAK2/STAT3 and TGF-β/Smad3 Pathways in vivo [Corrigendum]
Publicado: (2023)

Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
Publicado: (2013)

Corrigendum to “the long noncoding RNA MEG3 and its target miR-147 regulate JAK/STAT pathway in advanced chronic myeloid leukemia” [EBioMedicine 35 (2018) 61–75]
por: Li, Zi-ye, et al.
Publicado: (2018)

MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
por: Fan, Z, et al.
Publicado: (2016)

Phosphorylation of cortactin by cyclin-dependent kinase 5 modulates actin bundling by the dynamin 1-cortactin ring-like complex and formation of filopodia and lamellipodia in NG108-15 glioma-derived cells
por: Abe, Tadashi, et al.
Publicado: (2020)

The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
por: Derenzini, E, et al.
Publicado: (2014)

A key protein from Borrelia burgdorferi could stimulate cytokines in human microglial cells and inhibitory effects of Cucurbitacin IIa
por: Xu, Xin, et al.
Publicado: (2023)

STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma
por: Oi, Toru, et al.
Publicado: (2016)

Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation
por: Nitulescu, Ioana I., et al.
Publicado: (2017)

Alternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation
por: Timofeeva, Olga A., et al.
Publicado: (2012)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

Corrigendum to “Tanshinone IIA Alleviates CCL2-Induced Leaning memory and Cognition Impairment in Rats: A Potential Therapeutic Approach for HIV-Associated Neurocognitive Disorder”
por: Liao, Yuan-jun, et al.
Publicado: (2020)

miR-29a inhibits human retinoblastoma progression by targeting STAT3
por: Liu, Shu, et al.
Publicado: (2021)

Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3-FOXO1 signaling pathway
por: Jiang, Jian, et al.
Publicado: (2019)

Corrigendum to “Actin Alpha 2 (ACTA2) Downregulation Inhibits Neural Stem Cell Migration through Rho GTPase Activation”
por: Zhang, Ji, et al.
Publicado: (2020)

Corrigendum to “The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors” [Pharmacol. Res. 147 (2019) 104392]
por: Bechman, Katie, et al.
Publicado: (2020)

Class IIa HDACs in myelination
por: Velasco-Aviles, Sergio, et al.
Publicado: (2018)

Corrigendum to Yahong Liu, Qijian Feng, Jinhua Miao, et al. ‘C‐X‐C motif chemokine receptor 4 aggravates renal fibrosis through activating JAK/STAT/GSK3β/β‐catenin pathway’ Journal of Cellular and Molecular Medicine. 2020;24(7):3837–3855
Publicado: (2023)

Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
por: Cao, Yaoquan, et al.
Publicado: (2023)

A unified molecular mechanism for the regulation of acetyl-CoA carboxylase by phosphorylation
por: Wei, Jia, et al.
Publicado: (2017)

Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
por: Wang, Yu, et al.
Publicado: (2023)

Corrigendum to “EF24 Suppresses Invasion and Migration of Hepatocellular Carcinoma Cells In Vitro via Inhibiting the Phosphorylation of Src”
por: Zhao, Ran, et al.
Publicado: (2021)

Class IIa Bacteriocins: Diversity and New Developments
por: Cui, Yanhua, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_91rd21vlmmtr4ob7t05v2snnmj